Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2022-02-03
Product name
CareUS Malaria Rapydtest
1.2.2. Uses advised against
TEST: Medical device for professional in vitro diagnostic use only. Use for detection of malaria HRP2 and pLDH in human blood BUFFER: For use only with the supplied CareUS™ Malaria Rapydtest®
Manufacturer Name
Wells Bio, Inc
Emergency telephone
+44 (0)118 979 5566
Icons in SDS
Company Information
company name
Wells Bio, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
technical@apacor.com
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture No significant health effects are anticipated from using this product when used under normal operating conditions and in accordance with the kit specific instructions for use. The following are not considered as hazardous at the amounts shown below according to the latest edition of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) Monoclonal antibody (0.4µg/25 tests) Monoclonal antibody-dye conjugate (0.12µg/25 tests) Sodium Azide less than 0.1% Repeated or prolonged exposure is not known to aggravate any medical condition Classification according to Regulation (EC) No
Hazard statements
-
Precautionary statements
-
2.3 Other hazards
No information available. SDS015WB v1 03/02/2022
2.1 Classification of the substance or mixture
No significant health effects are anticipated from using this product when used under normal operating conditions and in accordance with the kit specific instructions for use. The following are not considered as hazardous at the amounts shown below according to the latest edition of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS): Monoclonal antibody (0.4µg/25 tests) Monoclonal antibody-dye conjugate (0.12µg/25 tests) Sodium Azide less than 0.1% Repeated or prolonged exposure is not known to aggravate any medical condition. 2.1.1 Classification according to Regulation (EC) No 1272/2008 [CLP]: Non-hazardous Eye Contact: Irritation. Tears. Skin Contact: Irritation. Ingestion: No known significant effect or critical hazard upon ingestion of assay buffer solution in the kit. Inhalation: None known. 2.2 Label elements Labelling according to Regulation (EC) No 1272/2008 [CLP] Hazard statement(s): - Precautionary statements: - 2.3 Other hazards No information available. SDS015WB v1 03/02/2022 SECTION 3 COMPOSITION/INFORMATION ON INGREDIENTS 3.2 Mixtures Hazardous ingredients according to Regulation (EC) No 1272/2008 Component: Sodium Azide CAS No: 26628-22-8 Concentration: <0.1% Hazard statement: non-hazardous at this concentration SECTION 4 FIRST AID MEASURES 4.1 Description of first aid measures If inhaled: remove to fresh air. Give artificial respiration to support vital functions. In case of skin contact: wash off immediately with soap and plenty of water. In case of eye contact: rinse thoroughly with plenty of water for at least 15 minutes. Ensure adequate flushing of the eyes by separating the eyelids with fingers. Consult a physician immediately. If swallowed: Do not induce vomiting. Rinse mouth with water. Consult a physician immediately. If symptoms persist, call a physician or poison control center. 4.2 Most important symptoms and effects, both acute and delayed No data available 4.3 Indication of any immediate medical attention and special treatment needed Treat symptomatically. SECTION 5 FIRE FIGHTING MEASURES 5.1 Extinguishing media Water spray, CO2, dry chemical, halon, foam & abc class. 5.2 Special hazards arising from the substance or mixture None. 5.3 Advice for firefighters Wear approved self-contained breathing apparatus for firefighting if necessary and full protective gear. SECTION 6 ACCIDENTAL RELEASE MEASURES 6.1 Personal precautions, protective equipment and emergency procedures Prevent contact with skin, eyes and clothes. Use personal protective equipment. Ensure adequate ventilation 6.2 Environmental precautions Avoid release to the environment. 6.3 Methods and material for containment and cleaning up Contain spillage, soak up with inert absorbent material then collect and place in container for disposal according to local regulations. 6.4 Reference to other sections SECTION 7 HANDLING AND STORAGE 7.1 Precautions for safe handling Follow Good Laboratory Practice, wear disposable gloves. Avoid contact and contamination with skin, eyes and clothes. Wash hands and any other exposed area with soap and water before eating, drinking, smoking, and leaving work place. 7.2 Conditions for safe storage, including any incompatibilities Store at room temperature, not above 40°C and not below 1°C. 7.3 Specific end use(s) No other specific uses are specified apart from those listed in Section 1.2. SECTION 8 EXPOSURE CONTROLS/PERSONAL PROTECTION 8.1 Control parameters No data available 8.2 Exposure controls 8.2.1 Appropriate engineering controls Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at the end of workday. Specimen collection and preparation: all the specimens should be considered potentially hazardous and handled in the same manner as an infectious agent. 8.2.2 Personal protective equipment (a) Eye/face protection: Tightly fitting safety goggles. Faceshield (8-inch minimum). Use equipment for eye protection tested and approved under appropriate government standards such as NIOSH (US) or EN 166(EU). (b) Skin protection: Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique (without touching glove's outer surface) to avoid skin contact with this product. Dispose of contaminated gloves after use in accordance with applicable laws and good laboratory practices. Wash and dry hands. The selected protective gloves should satisfy the specifications of EU Directive 89/686/EEC and the standard EN 374 derived from it. (c) Body Protection: The type of protective equipment must be selected according to the concentration and amount of the dangerous substance at the specific workplace. (d) Respiratory protection: No specific requirement when used under normal operating conditions. SDS015WB v1 03/02/2022 SECTION 9 PHYSICAL AND CHEMICAL PROPERTIES 9.1 Information on basic physical and chemical properties a) Appearance Test: White solid reaction strip in a plastic cassette. Buffer: brown liquid. b) Odour No data available c) Odour threshold Not applicable d) pH Buffer: 9.2 e) Melting point / freezing point Not applicable f) Initial boiling point and boiling range Buffer 100°C g) Flash point Not applicable h) Evaporation rate Not applicable i) Flammability (solid, gas) Not applicable j) Upper/lower flammability or explosive limits Not applicable k) Vapour pressure Not applicable l) Vapour density Not applicable m) Relative density No data available n) Solubility (ies) No data available o) Partition coefficient: n-octanol/water No data available p) Auto-ignition temperature Not applicable q) Decomposition temperature Not applicable r) Viscosity No data available s) Explosive properties No risk t) Oxidising properties Not applicable 9.2 Other information No data available SECTION 10 STABILITY AND REACTIVITY 10.1 Reactivity Not applicable. 10.2 Chemical stability Under storage at normal ambient temperatures the product is stable. 10.3 Possibility of hazardous reactions No data available. 10.4 Conditions to avoid None. 10.5 Incompatible materials None. 10.6 Hazardous decomposition products None. SECTION 11 TOXICOLOGICAL INFORMATION 11.1 Information of toxicological effects Acute toxicity: Product does not present an acute toxicity hazard based on known or supplied information. Skin corrosion/irritation: irritation. Serious eye damage/eye irritation: irritation. Respiratory or skin sensitisation: no data available Germ cell mutagenicity: no effects are known. Carcinogenicity: no effects are known. Reproductive toxicity: no effects are known. Specific target organ toxicity - single exposure: no data available Specific target organ toxicity - repeated exposure: no data available SECTION 12 ECOLOGICAL INFORMATION 12.1 Toxicity No data available. The product should be discarded in a proper biohazard container after testing. Do not allow product to reach ground water, water bodies or sewage system. 12.2 Persistence and degradability No data available 12.3 Bioaccumulative potential No data available 12.4 Mobility in soil No data available 12.5 Results of PBT and vPvB assessment No data available 12.6 Other adverse effects No data available 12.7 Additional information Do not allow to enter waters, drains or soil. SECTION 13 DISPOSAL CONSIDERATIONS 13.1 Waste treatment methods This material is not regarded as hazardous waste. Product: Dispose of in accordance with all federal, state, and local regulations. Contaminated packaging: Dispose of as unused product. Sodium azide (<0.1%) may react with lead or copper found in plumbing drains to form explosive compounds. Drain with copious amount of water to dilute solutions to prevent the buildup of shock sensitive compound. SECTION 14 TRANSPORT INFORMATION 14.1 UN number: - 14.2 UN proper shipping name: Not dangerous goods. 14.3 Transport hazard class(es): - 14.4 Packing group: - 14.5 Environmental hazards: - 14.6 Special precautions for user: - 14.7 Transport in bulk according to Annex II of MARPOL73/78 and the IBC Code Not intended to be transported in bulk. SECTION 15 REGULATORY INFORMATION 15.1 Safety, health and environmental regulations/ legislation specific for the substance or mixture This product does not require special labelling, in accordance with the appropriate EC directives. This product is for in vitro diagnostic use therefore must comply with the European Directive 98/79/EC regarding bearing the CE label prior to placing on the market. 15.2 Chemical Safety Assessment No chemical safety assessment has been carried out for this product. SDS015WB v1 03/02/2022 SECTION 16 OTHER INFORMATION For professional in vitro diagnostic use only. Consult instructions for use. References: Directives 1999/45/EC, 98/79/EC, 91/155/EC, 67/548/EEC Amended sections are indicated by a line in the border. The information supplied in this SDS is correct to the best of our knowledge. We do not accept any liability for loss, injury or damage, which may result from its use. MDSS GmbH Schiffaraben 41 30175 Hanover